Immuno-Oncology Drugs GLS-012 Alone & in Combination GLS-010 Treating With Advanced Patients Solid Tumors
Clinical trial NCT05909436 · RECRUITING
Trial details
- NCT number
- NCT05909436
- Sponsor
- Guangzhou Gloria Biosciences Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-31
- Primary completion
- 2026-12-01
- Enrollment
- 107
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.